Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway
文献类型：期刊论文
| 作者 | Li,Xu-xia; Zhang,Peng; Yang,Yang ; Wang,Jing-jing; Zheng,Yan-jun; Tan,Ji-liang; Liu,Shen-yan; Yan,Yong-ming; Zhang,You-yi; Cheng,Yong-xian
|
| 刊名 | ACTA PHARMACOLOGICA SINICA
 |
| 出版日期 | 2022 |
| 卷号 | 43期号:3页码:588-601 |
| ISSN号 | 1671-4083 |
| 关键词 | cardiac hypertrophy pyrazine derivative QF84139 phenylephrine transverse aortic constriction AMPK signaling pathway PROTEIN-KINASE MAMMALIAN TARGET OVERLOAD METFORMIN MACROPHAGES MECHANISMS MEDICINE ALPHA CELLS MODEL |
| DOI | 10.1038/s41401-021-00678-5 |
| 英文摘要 | Cardiac hypertrophy is a common adaptive response to a variety of stimuli, but prolonged hypertrophy leads to heart failure. Hence, discovery of agents treating cardiac hypertrophy is urgently needed. In the present study, we investigated the effects of QF84139, a newly synthesized pyrazine derivative, on cardiac hypertrophy and the underlying mechanisms. In neonatal rat cardiomyocytes (NRCMs), pretreatment with QF84139 (1-10 mu M) concentration-dependently inhibited phenylephrine-induced hypertrophic responses characterized by fetal genes reactivation, increased ANP protein level and enlarged cardiomyocytes. In adult male mice, administration of QF84139 (5-90 mg center dot kg(-1)center dot d(-1), i.p., for 2 weeks) dose-dependently reversed transverse aortic constriction (TAC)-induced cardiac hypertrophy displayed by cardiomyocyte size, left ventricular mass, heart weights, and reactivation of fetal genes. We further revealed that QF84139 selectively activated the AMPK signaling pathway without affecting the phosphorylation of CaMKII delta, ERK1/2, AKT, PKC epsilon, and P38 kinases in phenylephrine-treated NRCMs and in the hearts of TAC-treated mice. In NRCMs, QF84139 did not show additive effects with metformin on the AMPK activation, whereas the anti-hypertrophic effect of QF84139 was abolished by an AMPK inhibitor Compound C or knockdown of AMPK alpha 2. In AMPK alpha 2-deficient mice, the anti-hypertrophic effect of QF84139 was also vanished. These results demonstrate that QF84139 attenuates the PE- and TAC-induced cardiac hypertrophy via activating the AMPK signaling. This structurally novel compound would be a promising lead compound for developing effective agents for the treatment of cardiac hypertrophy. |
| WOS记录号 | WOS:000648507200001 |
| 源URL | [http://ir.kib.ac.cn/handle/151853/73161]  |
| 专题 | 中国科学院昆明植物研究所 |
| 作者单位 | 1.Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Cardiol, Shanghai 200233, Peoples R China 2.Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100101, Peoples R China 3.[Li, Xu-xia 4.Zhang, Peng 5.Zheng, Yan-jun 6.Tan, Ji-liang 7.Liu, Shen-yan 8.Chinese Acad Sci, Univ Chinese Acad Sci, CAS Key Lab Tissue Microenvironm & Tumor, Lab Mol Cardiol,Shanghai Inst Nutr & Hlth, Shanghai 200031, Peoples R China 9.[Yang, Yang 10.Yan, Yong-ming |
| 推荐引用方式 GB/T 7714 | Li,Xu-xia,Zhang,Peng,Yang,Yang,et al. Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway[J]. ACTA PHARMACOLOGICA SINICA,2022,43(3):588-601. |
| APA | Li,Xu-xia.,Zhang,Peng.,Yang,Yang.,Wang,Jing-jing.,Zheng,Yan-jun.,...&Yang,Huang-tian.(2022).Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway.ACTA PHARMACOLOGICA SINICA,43(3),588-601. |
| MLA | Li,Xu-xia,et al."Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway".ACTA PHARMACOLOGICA SINICA 43.3(2022):588-601. |
入库方式： OAI收割
来源：昆明植物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。